Pharmacological Treatment of Acute Coronary Syndromes
This book updates clinicians on the most recent data regarding the medical management of patients of acute coronary syndrome (ACS), providing useful information and expert opinion on the large trials, international guidelines, and clinical practice. It re
- PDF / 3,309,184 Bytes
- 260 Pages / 360.04 x 575.43 pts Page_size
- 92 Downloads / 195 Views
Pablo Avanzas Peter Clemmensen Editors
Pharmacological Treatment of Acute Coronary Syndromes
Current Cardiovascular Therapy
Pablo Avanzas • Peter Clemmensen Editors
Juan Carlos Kaski Series Editor
Pharmacological Treatment of Acute Coronary Syndromes
Editors Pablo Avanzas, MD, PhD, FESC Department of Cardiology Hospital Universitario Central de Asturias Oviedo Spain
Peter Clemmensen, MD, PhD, FESC Department of Cardiology The Heart Center Rigshospitalet University Hospital of Copenhagen Copenhagen Denmark
ISBN 978-1-4471-5423-5 ISBN 978-1-4471-5424-2 (eBook) DOI 10.1007/978-1-4471-5424-2 Springer London Heidelberg New York Dordrecht Library of Congress Control Number: 2013950913 © Springer-Verlag London 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher's location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
This book is dedicated to Prof. Juan Carlos Kaski, President of ISCP
Series Preface
Cardiovascular pharmacotherapy is of fundamental importance for the successful management of patients with cardiovascular diseases. Appropriate therapeutic decisions require a proper understanding of the disease and a thorough knowledge of the pharmacological agents available for clinical use. The issue is complicated by the existence of large numbers of agents with subtle differences in their mode of action and effi
Data Loading...
